Gary Edward Zurenko

This inventor holds 3 USPTO granted patents. Top assignees: The Upjohn Co., Pharmacia & Upjohn Company. Active years: 1988-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Edward Zurenko. Retrieved from https://idiyas.com/inventor/gary-edward-zurenko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 66.7

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 50(Granted Patents)

Location History:

Alamo Township, Kalamazoo County, MI (US) (1990)
Kalamazoo, MI (US) (1988 - 2003)

Company Filing History:

Pharmacia & Upjohn Company

patents

Years Active: 1988-2003

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6605609 - Thizaine oxazolidinone (2003-08-12),

2. 4895870 - Treating chlamydia infections using spectinomycin analogs (1990-01-23),

3. 4749568 - Rubradirin treatment of methicillin-resistant staph (1988-06-07),

Title: Gary Edward Zurenko: Innovator in Antimicrobial Research

Introduction

Gary Edward Zurenko is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of antimicrobial research, holding a total of 3 patents. His work has focused on developing innovative solutions to combat infections, particularly those caused by chlamydia.

Latest Patents

Zurenko's latest patents include a thizaine oxazolidinone, which is useful as an antimicrobial agent. Additionally, he has developed methods for treating chlamydia infections using spectinomycin analogs. These inventions highlight his commitment to advancing medical science and improving treatment options.

Career Highlights

Throughout his career, Zurenko has worked with prominent companies in the pharmaceutical industry, including The Upjohn Company and Pharmacia & Upjohn Company. His experience in these organizations has allowed him to contribute to significant advancements in drug development and antimicrobial therapies.

Collaborations

Zurenko has collaborated with esteemed colleagues such as Michael R. Barbachyn and Fritz Reusser. These partnerships have fostered innovation and have been instrumental in the success of his research endeavors.

Conclusion

Gary Edward Zurenko's contributions to antimicrobial research and his innovative patents demonstrate his dedication to improving healthcare. His work continues to influence the field and offers promising solutions for treating infections.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]